Biomedical engineers at Duke University have developed a platform that combines automated wet lab techniques with artificial ...

Researchers at the University of Toronto say they have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine ...

Keytruda Qlex is a fixed combination of pembrolizumab, a PD-1-blocking antibody, and berahyaluronidase alfa, a variant of human hyaluronidase. The addition of berahyaluronidase enhances dispersion and ...

New York, June 09, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Drug Formulation Global Market Report 2023" - https://www ...

Pharmacists at St. Jude Children’s Research Hospital in Memphis, Tenn., have started using 3D-printing technology to help produce compounded medications starting with hydrocortisone formulations. The ...

The protein therapeutics market totaled $63 billion in 2007 ($39 billion in the U.S. alone) and is expected to reach $87 billion by 2010, according to a report by Kalorama Information—“Protein ...

Intrepid Labs’ Valiant platform uses AI and robotics to cut drug formulation timelines from months to days Over $11M USD total raised to-date; latest round led by AVANT BIO The company has secured ...

ANDOVER, Mass.--(BUSINESS WIRE)--Feb 11, 2010 - Today, Formatech, Inc. announced the issuance of U.S. patent 7,659,310, entitled "Methods of Enhancing Solubility of Agents" which covers novel ...

Aphaia’s lead formulation orchestrates a comprehensive hormonal response from nutrient-sensing cells with potential to modify the course of obesity and associated metabolic diseases.It is currently ...

The FDA has approved Keytruda Qlex, a faster, under-the-skin cancer treatment offering convenience and flexibility. Here's ...